Cancer researchers in Bergen have helped to develop a new technology that could customise and improve the treatment of endometrial (uterine) cancer patients. Bergen Teknologioverføring (BTO), a company specialised in commercialising research results, helped the researchers to get their licensing structure in place.
“It is a good feeling to help along such important research that can benefit society,” says Berit Bjørnhaug, a legal adviser at BTO.
To read the full, original article click on this link: Health News - Taking cancer research from lab to patients
